Therefore, the complete elucidation of the molecular mechanisms, regulating vaspin, would gain a new insight into the pathogenesis of MetS, and, as a compensatory molecule in this process, a vaspin recombinant protein or vaspin analogs, antibodies, or small molecule agents might be candidates, underlying new therapeutic agents [7, 15]. This evidence concerns the gene SERPINA12 and metabolic syndrome.